We’re pleased to announce Signatope’s participation in the 2nd ISSX 2-Day Workshop on Quantitative LC-MS/MS Proteomics, scheduled for June 27-28, 2024, at the Certara UK Offices in Sheffield, UK.
Our CEO, Oliver Pötz, alongside Senior Scientist Helen Hammer, will present on the first day of the workshop. They will delve into essential considerations for setting up a quantitative proteomics lab, offering insights based on their extensive expertise.
This workshop is a valuable opportunity for those involved in translational DMPK/PD and precision medicine to deepen their understanding and refine their research approaches. It’s particularly beneficial for researchers eager to enhance their lab techniques and avoid common challenges in proteomics.
For more information and to register, please visit the ISSX website.